Encellin's insulin therapy featured on NPR's All Things Considered

2017 Rosenman Innovator Encellin and founder and CEO Crystal Nyitray featured recently on the nation's premier public radio forum.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

 A coin-sized, semipermeable pouch is key to the proposed implant. The pouch allows cells inside to thrive and release insulin, the researchers say, while protecting the cells from immune rejection.  Courtesy of Encellin

A coin-sized, semipermeable pouch is key to the proposed implant. The pouch allows cells inside to thrive and release insulin, the researchers say, while protecting the cells from immune rejection. Courtesy of Encellin

Scientists in California think they may have found a way to transplant insulin-producing cells into diabetic patients who lack those cells — and protect the little insulin-producers from immune rejection. Their system, one of several promising approaches under development, hasn't yet been tested in people. But if it works, it could make living with diabetes much less of a burden.

For now, patients with Type-1 diabetes have to regularly test their blood sugar levels, and inject themselves with insulin when it's needed.

Some researchers are developing machines to automate that process.

But Crystal Nyitray, founder and CEO of the biotechnology startup Encellin, in San Francisco, didn't want to use a machine to treat diabetes. As a graduate student in bioengineering at the University of California, San Francisco a few years ago, Nyitray wanted to try something different: living cells.

Read the full story on the NPR website

Green Sun Medical awarded $50K for scoliosis brace at prestigious pediatric medical device competition

Green-Sun-Medical-scoliosis-brace-1.jpg

2017 Rosenman Innovator Green Sun Medical was awarded the top cash prize of $50,000 during the FDA-sponsored pediatric medical device competition at the Fifth Annual Pediatric Device Innovation Symposium in San Jose, Calif. organized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

Green Sun Medical is developing a dynamic scoliosis brace that will allow physicians to remotely monitor the performance on the patients.

“We are honored to have our scoliosis brace recognized with these other pediatric device innovations,” said Jamie Haggard, CEO of Green Sun Medical.  He also said that current treatments include braces developed over 40 years ago and spinal fusion surgeries.

Read the full story at OrthoSpineNews

Channel Medsystems® Secures $14.1M Financing

Congratulations to Rosenman Fellow Bill Malecki, co-founder, COO, and CTO of Channel Medsystems!

>>>>>>>>>>>>>>>>>>>>>>>>>>>>

EMERYVILLE, Calif., Aug. 23, 2017 /PRNewswire/ -- Channel Medsystems, developer of an innovative, physician office-based therapy for heavy menstrual bleeding, announced today that it has secured a $14.1mm Series C-1 financing.  The insider-led round included participation by Third Point Ventures, InCube Ventures, Aperture Venture Partners, Scientific Health Development, Longwood Fund, and Boston Scientific.

Channel Medsystems has developed the Cerene® Cryotherapy Device to treat heavy menstrual bleeding.  Cerene allows women who are finished with childbearing to receive treatment in their gynecologist's office, a more comfortable and less-expensive setting of care than a hospital or surgery center. The Company plans to use this funding to support initiatives leading up to anticipated FDA approval as well as initial preparation for commercial launch.

Read the full press release